Search results for "Radiotherapy Dosage"

showing 10 items of 73 documents

Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients—Acute Toxicity and Treatment Quality of the Ute…

2015

The Uterus-11 trial was designed to evaluate the role of surgical staging in patients with cervical cancer before primary chemoradiation therapy (CRT). The present report provides the toxicity data stratified by the treatment arm and technique.A total of 255 patients with carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics stage IIB-IVA) were randomized to either surgical staging followed by CRT (arm A) or clinical staging followed by CRT (arm B). Patients with para-aortic metastases underwent extended field radiation therapy (RT). Brachytherapy was mandatory. The present report presents the acute therapy-related toxicities stratified by treatment arm and …

0301 basic medicineCancer Researchmedicine.medical_treatmentBrachytherapyUterine Cervical NeoplasmsCarboplatinlaw.invention0302 clinical medicineRandomized controlled trialLeukocytopenialawGermanyProspective StudiesStage (cooking)Cervical cancerRadiationRadiotherapy DosageChemoradiotherapyMiddle AgedOncology030220 oncology & carcinogenesisCarcinoma Squamous CellFemaleAdultmedicine.medical_specialtyBrachytherapyAntineoplastic AgentsContext (language use)AdenocarcinomaDisease-Free SurvivalCarcinoma AdenosquamousYoung Adult03 medical and health sciencesmedicineHumansRadiology Nuclear Medicine and imagingAgedNeoplasm Stagingbusiness.industrymedicine.diseaseSurgeryRadiation therapy030104 developmental biologyGynecologyRadiation OncologyLymph Node ExcisionRadiotherapy Intensity-ModulatedCisplatinbusinessChemoradiotherapyInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Relapse Analysis of Irradiated Patients Within the HD15 Trial of the German Hodgkin Study Group

2015

Purpose To determine, in the setting of advanced-stage of Hodgkin lymphoma (HL), whether relapses occur in the irradiated planning target volume and whether the definition of local radiation therapy (RT) used by the German Hodgkin Study Group (GHSG) is adequate, because there is no harmonization of field and volume definitions among the large cooperative groups in the treatment of advanced-stage HL. Methods and Materials All patients with residual disease of ≥2.5 cm after multiagent chemotherapy (CTX) were evaluated using additional positron emission tomography (PET), and those with a PET-positive result were irradiated with 30 Gy to the site of residual disease. We re-evaluated all sites o…

AdultCancer ResearchNeoplasm Residualmedicine.medical_treatmentPlanning target volumeIrradiated VolumeBleomycinFluorodeoxyglucose F18RecurrenceGermanyAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineCooperative groupRadiology Nuclear Medicine and imagingRadiation treatment planningCyclophosphamideEtoposideChemotherapyRadiationmedicine.diagnostic_testbusiness.industryRadiotherapy Planning Computer-AssistedRadiotherapy DosageMiddle AgedCombined Modality TherapyHodgkin DiseaseRadiation therapyOncologyDoxorubicinVincristinePositron emission tomographyPositron-Emission TomographyProcarbazinePrednisoneHodgkin lymphomaRadiopharmaceuticalsbusinessNuclear medicineInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapy

2015

Abstract Background and purpose To analyze the distribution of individually-determined radiation dose to the heart and its functional sub-structures after radiotherapy in breast cancer patients treated in Germany during 1998–2008. Material and methods We obtained electronic treatment planning records for 769 female breast cancer patients treated with megavoltage tangential field radiotherapy. All dose distributions were re-calculated using Eclipse with the anisotropic analytical algorithm (AAA) for photon fields, and the electron Monte Carlo algorithm for electron boost fields. Based on individual dose volume histograms for the complete heart and several functional sub-structures, we estima…

AdultDose-volume histogrammedicine.medical_treatmentBreast Neoplasms030218 nuclear medicine & medical imaging03 medical and health sciencesQuadrant (abdomen)0302 clinical medicineBreast cancerHumansMedicineDosimetryRadiology Nuclear Medicine and imagingBreastRadiation treatment planningAgedbusiness.industryRadiotherapy Planning Computer-AssistedHeartRadiotherapy DosageHematologyMiddle Agedmedicine.diseaseRadiation therapyOncologyParasternal line030220 oncology & carcinogenesisFemalebusinessNuclear medicineMonte Carlo MethodBody mass indexRadiotherapy and Oncology
researchProduct

NK/T-cell lymphomas 'nasal type': an italian multicentric retrospective survey

2006

Abstrac Objective: To evaluate the clinical characteristics and outcome of NK/T-cell lymphoma ‘nasal type’ developed in Italian patients. Patients: Between 1997 and 2004, 26 new cases of NK/T-cell lymphoma ‘nasal type’ were diagnosed in 10 Italian Hematology institutions. Results: All patients were Caucasian, male/female ratio was 19/7, with a median age of 50 years (range 20–80). In 23 cases presentation at the onset was in the nasal cavity or adjacent structures, in two cases the lymphoma onset with skin lesions was followed successively by rhynopharyngeal dissemination, while the remaining case had bone marrow and lymph node involvement followed by oro-pharyngeal involvement. Regarding t…

AdultMaleNasal cavitymedicine.medical_specialtymedicine.medical_treatmentNK/T cellNose NeoplasmsAntineoplastic AgentsLymphoma T-CellNose neoplasmGastroenterologyNK/T cell lymphoma treatmentInternal medicinemedicineHumansStage (cooking)Survival rateAgedNeoplasm StagingRetrospective StudiesAged 80 and overChemotherapybusiness.industryRadiotherapy DosageHematologylymphoma treatmentMiddle AgedPrognosismedicine.diseaseCombined Modality TherapyHealth SurveysChemotherapy regimenLymphomaSurgeryKiller Cells NaturalSurvival RateRadiation therapymedicine.anatomical_structureOncologyFemaleNasal Cavitylymphoma treatment; nk/t cellbusiness
researchProduct

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.

2003

Aim  The standard treatment for patients with clinically resectable rectal cancer is surgery. Postoperative radiochemotherapy (RCT) is recommended for advanced disease (pT3/4 or pN+). In recent years, encouraging results of pre-operative radiotherapy have been reported. This prospective randomized phase-III-trial (CAO/ARO/AIO-94) compares the efficacy of neoadjuvant RCT to standard postoperative RCT. We report on the design of the study and first results with regard to toxicity of RCT and postoperative morbidity. Patients and methods  Patients with locally advanced operable rectal cancer (uT3/4 or uN+, Mason CS III/IV) were randomly assigned to pre or postoperative RCT: A total dose of 50.4…

AdultMalemedicine.medical_specialtyAntimetabolites AntineoplasticNauseaColorectal cancermedicine.medical_treatment030230 surgerylaw.invention03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRandomized controlled triallawGermanymedicineHumansAgedNeoplasm Stagingbusiness.industryRectal NeoplasmsStandard treatmentPatient SelectionGastroenterologyPostoperative complicationRadiotherapy DosageMiddle Agedmedicine.diseaseTotal mesorectal excisionSurvival AnalysisNeoadjuvant Therapy3. Good healthSurgeryClinical trialRadiation therapyTreatment OutcomeChemotherapy Adjuvant030220 oncology & carcinogenesisQuality of LifeFemaleRadiotherapy AdjuvantFluorouracilmedicine.symptombusinessColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
researchProduct

Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center expe…

2018

Background: Several experiences in the literature report SBRT as an effective treatment option for medically inoperable early stage non-small cell lung cancer (NSCLC) and oligometastatic disease. The optimal fractionation schedules and total dose remain controversial. In this study, we evaluated the safety in terms of toxicity and efficacy of using of 8–10 fractions schedules with Helical Tomotherapy (HT) for primary and metastatic lung lesions. Methods: Between March 2014 and May 2016, a total of 39 patients (median age 72 years, range 26–91) were treated with HT-SBRT for malignant lung lesions: 22 patients with early stage NSCLC, 17 with oligometastases. Patients received 8–10 fract…

AdultMalemedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentStereotactic radiation therapyRadiosurgerySingle CenterTomotherapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineHelical tomotherapyCarcinoma Non-Small-Cell LungmedicineHumansRadiology Nuclear Medicine and imagingStage (cooking)Lung cancerAgedPneumonitisAged 80 and overSBRTHelical tomotherapy; Lung cancer; Radiotherapy; SBRTRadiotherapybusiness.industryRadiotherapy DosageGeneral MedicineMiddle Agedmedicine.diseaseSurvival RateRadiation therapyTreatment Outcome030220 oncology & carcinogenesisFeasibility StudiesFemaleDose Fractionation RadiationRadiologyLung cancerbusinessTomography Spiral ComputedEsophagitis
researchProduct

Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study

2017

Abstract Introduction Aim of the present study is to evaluate homolateral and contralateral hippocampus (H-H, C-H, respectively) dose during Fractionated Stereotactic Radiotherapy (FSRT) or Radiosurgery (SRS) for brain metastases (BM). Materials & methods Patients with BM   3 months, were considered for SRS/FSRT (total dose 15–30 Gy, 1–5 fractions). For each BM, a Flattening Filter Free (FFF) Volumetric Modulated Arc Therapy (VMAT) plan was generated with one or two arcs. Hippocampi were not considered during optimizations phase and were contoured and evaluated retrospectively in terms of dose: the Dmedian, Dmean, D0.1cc and the V1Gy, V2Gy, V5Gy and V10Gy were analyzed. Results From April 2…

AdultMalemedicine.medical_treatmentBiophysicsGeneral Physics and AstronomyStereotactic fractionatedHippocampal formationRadiation DosageRadiosurgeryHippocampusRadiosurgery030218 nuclear medicine & medical imagingStereotactic radiotherapyYoung AdultPhysics and Astronomy (all)03 medical and health sciences0302 clinical medicineNuclear Medicine and ImagingStereotactic radiotherapymedicineHumansRadiology Nuclear Medicine and imagingIn patientHippocampiAgedAged 80 and overRadiotherapyBrain Neoplasmsbusiness.industryRadiotherapy DosageBrain metastasesGeneral MedicineMiddle AgedBrain metastases; Hippocampi; Radiotherapy; Stereotactic fractionated; Stereotactic radiotherapy; Biophysics; Radiology Nuclear Medicine and Imaging; Physics and Astronomy (all)Volumetric modulated arc therapyRadiation therapy030220 oncology & carcinogenesisTotal doseFemaleDose reductionParticle AcceleratorsRadiologybusinessNuclear medicinePhysica Medica
researchProduct

The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients

1992

CORT is a new radiosurgical treatment concept for patients with recurrent gynecologic malignancies infiltrating the pelvic wall. The operative part consists of (i) staging laparotomy; (ii) maximum debulking of the tumor from the pelvic wall and exenteration of infiltrated central pelvic organs; (iii) implantation of brachytherapy guiding tubes on the residual tumor/tumor bed at the pelvic wall; (iv) pelvic wall plasty with muscle and omentum flaps to create a protective distance between the tubes and the pelvic hollow organs and to induce therapeutic angiogenesis; and (v) surgical reconstruction of bowel, bladder, and vulvoperineovaginal functions. Radiation is given postoperatively as frac…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentBrachytherapyBrachytherapyWhole-PelvisPelvic wallHumansMedicineProspective StudiesPelvic NeoplasmsPelvic organbusiness.industryPrior RadiationOperative mortalityObstetrics and GynecologyRadiotherapy DosageGeneral MedicineMiddle AgedPrognosisDebulkingCombined Modality TherapySurgeryRadiation therapyOncologyFemalebusinessPelvic radiotherapyInternational Journal of Gynecology & Obstetrics
researchProduct

Fetal dose measurements and shielding efficiency assessment in a custom setup of (192)Ir brachytherapy for a pregnant woman with breast cancer.

2015

To assess the radiation dose to the fetus of a pregnant patient undergoing high-dose-rate (HDR) (192)Ir interstitial breast brachytherapy, and to design a new patient setup and lead shielding technique that minimizes the fetal dose.Radiochromic films were placed between the slices of an anthropomorphic phantom modeling the patient. The pregnant woman was seated in a chair with the breast over a table and inside a leaded box. Dose variation as a function of distance from the implant volume as well as dose homogeneity within a representative slice of the fetal position was evaluated without and with shielding.With shielding, the peripheral dose after a complete treatment ranged from 50 cGy at…

Adultmedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyBiophysicsGeneral Physics and AstronomyFetal positionBreast NeoplasmsIonizing radiationLead shieldingBreast cancerFetusRadiation ProtectionPregnancymedicineHumansRadiology Nuclear Medicine and imagingRadiometrybusiness.industryRadiotherapy Planning Computer-AssistedRadiotherapy DosageGeneral Medicinemedicine.diseaseIridium RadioisotopesSurgeryRadiation therapyPregnancy ComplicationsElectromagnetic shieldingFemaleImplantbusinessNuclear medicinePhysica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
researchProduct

A dosimetric study of Leipzig applicators.

2005

Purpose: To obtain the absolute dose-rate distribution in liquid water for all six cup-shaped Leipzig applicators by means of an experimentally validated Monte Carlo (MC) code. These six applicators were used in high-dose-rate (HDR) afterloaders with the “classic” and v2 192Ir sources. The applicators have an inner diameter of 1, 2, and 3 cm, with the source traveling parallel or perpendicular to the contact surface. Methods and materials: The MC GEANT4 code was used to obtain the dose-rate distribution in liquid water for the six applicators and the two HDR source models. To normalize the applicator output factors, a MC simulation for the “classic” and v2 sources in air was performed to es…

Cancer ResearchRadiationDosimeterbusiness.industryPhantoms Imagingmedicine.medical_treatmentBrachytherapyMonte Carlo methodBrachytherapyWaterRadiotherapy DosageIridium RadioisotopesImaging phantomKermaOpticsOncologyIonization chamberPerpendicularmedicineDosimetryRadiology Nuclear Medicine and imagingThermoluminescent DosimetrybusinessNuclear medicineMonte Carlo MethodInternational journal of radiation oncology, biology, physics
researchProduct